Earnings Estimates Moving Higher for Amicus Therapeutics (FOLD): Time to Buy? Amicus Therapeutics (FOLD) shares have started gaining and might continue moving higher in the near term, as indicated by solid…
Does Amicus Therapeutics (FOLD) Have the Potential to Rally 138.21% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 138.2% in Amicus Therapeutics (FOLD).…
Amicus (FOLD) Q2 Revenue Jumps 22% Key PointsGAAP revenue reached $154.7 million in Q2 2025, This represented a 22% year-over-year increase in the second quarter of…
Amicus Therapeutics to Present at Upcoming Investor Conferences in June 2025 PRINCETON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate…
Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release Amicus Therapeutics (FOLD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue? Amicus Therapeutics (FOLD) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Amicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -10% and 0.13%, respectively, for the quarter ended December 2024. Do…
Insights Into Amicus Therapeutics (FOLD) Q4: Wall Street Projections for Key Metrics Besides Wall Streets top -and-bottom-line estimates for Amicus Therapeutics (FOLD), review projections for some of its key metrics to gain…
Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release Amicus Therapeutics (FOLD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President…
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024 PRINCETON, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will…
Amicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar? Amicus Therapeutics (FOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate…
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024 PRINCETON, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate…
Earnings call: Amicus Therapeutics highlights solid Q1 growth, raises guidance By Investing.com Earnings call: Amicus Therapeutics highlights solid Q1 growth, raises guidance…